PAGE 19
HIV NUTRITION UPDATE
VOLUME 8, ISSUE 4
Specific Uses of Supplements for HIV/AIDS
in the Post-HAART Era
(Continued from page 10)

22. Project Inform, Inc. Mitochondrial Toxicity And Lactic Acidosis. Fact Sheet, April 2001. Available at: 

23. Lafeuillade A, Hittinger G, Chadapaud S. Increased Mitochondrial Toxicity With Ribavirin In HIV/HCV Co-Infection. Lancet 2001;357(9252):280-1.

24. de la Asuncion JG, del Olmo ML, Sastre J, et al. AZT Treatment Induces Molecular And Untrastructural Oxidative Damage To Muscle Mitochondria. Prevention By Antioxidant Vitamins. J Clin Invest 1998;102(1):4-9. 

25. Claessens YE, Chiche JD, Mira JP, et al. Bench-to-Bedside Review: Severe Lactic Acidosis In HIV Patients Treated With Nucleoside Analogue Reverse Transcriptase Inhibitors. Crit Care 2003;7(3):226-32.

26. Claessens YE, Cariou A, Monchi M, et al. Detecting Life-Threatening Lactic Acidosis Related To Nucleoside-Analog Treatment Of Human Immunodeficiency Virus-Infected Patients, And Treatment With L-carnitine. Crit Care Med 2003;31(4):1042-7.

27. Cohen RD. The Metabolic Background To Acid-Base Homeostasis And Some Of Its Disorders: Lactic Acidosis. In: Cohen RD, Lewis B, Alberti KG, Denman AM, Editors. The Metabolic and Molecular Basis of Acquired Disease. W.B. Saunders: Philadelphia, PA. 1990:981-988.

28. Greenberg A, Cheung AK, Coffman TM, Jennette JC, Falk RJ, Editors, National Kidney Foundation. Primer On Kidney Diseases. 2nd Edition. Academic Press: San Diego, CA. 1998:76-77. 

 

29. Acosta B, Grimsley E. Ziduvudine-Associated Type B Lactic Acidosis And Hepatic Steatosis In An HIV-Infected Patient. South Med J 1999;92;421-423.

30. Roy PM, Gouello JP, Pennison-Besnier I, et al. Severe Lactic Acidosis Induced By Nucleoside Analogues In An HIV-Infected Man. Ann Emerg Med 1999;34:(2):282-284.

31. Carr A. Lactic Acidemia In Infection With Human Immunodeficiency Virus. Clin Infect Dis 2003;36(Suppl 2):S96-100.

32. Bonnet F, Bonarek M, Morlat P, et al. Risk Factors For Lactic Acidosis In HIV-Infected Patients Treated With Nucleoside Reverse-Transcriptase Inhibitors: A Case-Control Study. Clin Infect Dis 2003;36(10):1324-8. Epub 2003 May 02. 

33. Fouty B, Frerman F, Reves R. Riboflavin To Treat Analogue Induced Lactic Acidosis. Lancet 1998;352(9124):291-2. 

34. Meurin P. Shoshin Beriberi: A Rapidly Curable Hemodynamic Disease. Presse Med 1996;25(24):1115-8. 

35. Dalton SD, Rahimi AR. Emerging Role Of Riboflavin In The Treatment Of Nucleoside Analogue Induced Type B Lactic Acidosis. AIDS Patient Care STDS 2001;15(12):611-4. 

36. Posteraro AF 3rd, Mauriello M, Winter SM. Riboflavin Treatment Of Antiretroviral Induced Lactic Acidosis And Steatosis. Conn Med 2001;65(7):387-90. 

37. Schramm C, Wanitschke R, Galle PR. Thiamine For The Treatment Of Nucleoside Analogue Induced Severe Lactic Acidosis. Eur J Anaesthesiol 1999;16(10):733-5.

38. Luzzati R, Del Bravo P, Di Perri G, et al. Riboflavine And Severe Lactic Acidosis. Lancet 1999;353(9156):901-2.

39. McComsey GA, Lederman MM. High Doses Of Riboflavin And Thiamine May Help In The Secondary Prevention Of Hyperlactatemia. AIDS Read 2002;12(5):222-4.

40. Kanter AS, Spencer DC, Steinberg MH, et al. Supplemental Vitamin B And Progression To AIDS And Death In Black South African Patients Infected With HIV. J Acquir Immune Defic Syndr 1999;21(3):252-3.

41. Chan A, Reichmann H, Kogel A, et al. Metabolic Changes In Mitochondrial Myopathies And Effects Of Coenzyme Q10 Therapy. J Neurol 1998;245(10):681-5.
 
 
 

(Forward to page 20)


 
 

 
 
Copyright 2004 HIV ReSources, Inc. Sharing this newsletter in any form with non-subscribers is strictly prohibited. Library/Institution subscribers are permitted to share HIV Nutrition Update html newsletter pages with up to five (5) employees or volunteers. NO other redistribution allowed. 
 
Please Help To Keep This Page Updated By Notifying
The Webmaster If You Find A Link That's Outdated!
 
HIV ReSources, Inc.
PO Box 39385
Fort Lauderdale, FL
33339-9385
USA
 
© 2004  HIV ReSources, Inc.
Any use of the information presented herein is done strictly at your own risk.
No responsibility is implied or intended on the part of HIV ReSources Inc,
the editor, or the publisher. Information on this site should not
be construed as an endorsement of any kind.
 
2/1/2004